Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAN-STAR: Pantoprazole 40 mg for treatment and symptom relief in gastroesophageal reflux disease
2009-017229-20Phase 4Completed
- Sponsor
- Krka
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of pantoprazole in gastroesophageal reflux disease (GERD), erosive esophagitis (EE) and Non-erosive Gastroesophageal Reflux Disease (NERD), sponsored by Krka. Primary endpoint: Efficacy of pantoprazole 40 mg in GERD (reflux esophagitis and NERD). Started Dec 2009; status: completed.
02
Drugs
pantoprazole
03
Conditions
gastroesophageal reflux disease (GERD)erosive esophagitis (EE)Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on 2009-017229-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017229-20.